Home › Schizophrenia › New Jersey
Schizophrenia clinical trials in New Jersey
13 studies for Schizophrenia are looking for participants at sites in New Jersey.
Cities in New Jersey
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Hackensack Meridian Health - Carrier Clinic, Belle Mead
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07101094NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Marlton
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Marlton
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07227818A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0146, Neptune City
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 22, 2026 · NCT07424404A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Hassman Research Institute, LLC, Marlton
RecruitingPhase 1
Ages 18 to 55 · All sexes · Updated Sep 17, 2026 · NCT07734493A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Cenexel Hassman Research Institute (Hri) /ID# 276128, Marlton
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 15, 2026 · NCT07145918A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Hassman Research Institute Marlton Site, Marlton
RecruitingPhase 1
Ages 18 to 55 · All sexes · Updated Sep 2, 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Marlton
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Cenexel HRI, Marlton
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Jun 23, 2026 · NCT07191483A Study to Evaluate the Effect of KarXT on Urological Safety
- Hassman Research Institute Marlton Site, Marlton
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Jun 3, 2026 · NCT07221877Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
- Center for Advanced Human Brain Imaging Research, Piscataway
RecruitingHealthy volunteers welcome
Ages 18 to 50 · All sexes · Updated Mar 11, 2026 · NCT06745479NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Marlton
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Mar 6, 2026 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Marlton
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jan 12, 2026 · NCT06961968From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.